Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

Using AI to improve standard-of-care cardiac imaging

Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram, or cardiac ultrasound, is one of the most commonly used imaging ...

page 6 from 40